Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Raymond Vanholder, MD, PhD
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment
Patients will be treated with hemodiafiltration (HDF) in postdilution mode, as a control therapy, during 9 weeks. During week 5 the 1st intervention treatment, predilution hemofiltration (...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Uremic Toxins in the Intensive Care Unit (ICU): Patients With Sepsis
Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients with sepsis/multi-organ failure. The sampling of blood...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Raymond Vanholder, MD, PhD
Update Il y a 4 ans
Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis
Dialysis patients, who decide to switch from standard dialysis (3 times 240-270 min/week) to nocturnal dialysis (3 times 480 min/week), will be followed. In parallel a control group with p...
Country
Belgium
organs
None
Specialty
None
Closed trial
More information
Previous
1
2